Repurposing itraconazole as an anticancer agent.

Tsubamoto, Hiroshi; Ueda, Tomoko; Inoue, Kayo; Sakata, Kazuko; Shibahara, Hiroaki; Sonoda, Takashi

Tsubamoto, Hiroshi; Ueda, Tomoko; Inoue, Kayo; Sakata, Kazuko; Shibahara, Hiroaki; Sonoda, Takashi.

Afiliação

Tsubamoto H; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Ueda T; Department of Medical Oncology, Meiwa Hospital, Nishinomiya, Hyogo 663-8186, Japan.
Inoue K; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Sakata K; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Shibahara H; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.
Sonoda T; Department of Obstetrics and Gynecology, Hyogo College of Medicine, Nishinomiya, Hyogo 663-8501, Japan.

Oncol Lett ; 14(2): 1240-1246, 2017 Aug.

Article em En | MEDLINE | ID: mdl-28789339

Palavras-chave

Hedgehog; P-glycoprotein; Wnt/ß-catenin; anticancer; cancer-associated fibroblasts; itraconazole; mTOR; repositioning; repurposing

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncol Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão País de publicação: Grécia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google